Ancient herbs meet modern medicine in fight against aggressive lung cancer

NCT ID NCT07390565

ENROLLING_BY_INVITATION Disease control Sponsor: LI FENG Source: ClinicalTrials.gov ↗

Summary

This study is testing whether adding a traditional Chinese herbal formula called Yishen Qutong Granules to standard chemotherapy and immunotherapy helps people with advanced small cell lung cancer. Researchers will enroll 308 newly diagnosed patients to see if the herbal addition improves disease control, extends survival, and reduces treatment side effects compared to standard treatment alone. The goal is to see if this combined approach can better manage this aggressive cancer while improving patients' quality of life.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EXTENSIVE-STAGE SMALL CELL LUNG CANCER (SCLC) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Cancer Hospital, Chinese Academy of Medical Sciences/Peking Union Medical College

    Beijing, Chaoyang, 100021, China

Conditions

Explore the condition pages connected to this study.